Western blot in vivo was used to test whether GDC and baicalin improved lipid accumulation in diabetic nephropathy mice through SIRT1/AMPK/HNF4A (Figures 4(a)–4(d)). Here, PRKAA2 is linked to diabetic kidney disease.